VCAM-1/alpha 4-integrin adhesion pathway: therapeutic target for allergic inflammatory disorders (Q38350992)

2 September 2017

1 reference

title

VCAM-1/alpha 4-integrin adhesion pathway: therapeutic target for allergic inflammatory disorders (English)

1 reference

2 September 2017

0 references

Foster CA

1

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 December 1996

1 reference

The Journal of Allergy and Clinical Immunology

2 September 2017

published in

1 reference

2 September 2017

volume

98

1 reference

2 September 2017

issue

6 Pt 2

1 reference

2 September 2017

page(s)

S270-7

1 reference

Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Chemokines, leukocyte trafficking, and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

CC chemokines in allergic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

VLA proteins in the integrin family: structures, functions, and their role on leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

NF-kappa B: a lesson in family values

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Structure, regulation and function of NF-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Inhibition of NF-κB by Pyrrolidine Dithiocarbamate Blocks Endothelial Cell Activation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Proteolytic degradation of MAD3 (I kappa B alpha) and enhanced processing of the NF-kappa B precursor p105 are obligatory steps in the activation of NF-kappa B.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Inhibition of E-selectin-, ICAM-1-, and VCAM-1-mediated cell adhesion by benzo[b]thiophene-, benzofuran-, indole-, and naphthalene-2-carboxamides: identification of PD 144795 as an antiinflammatory agent

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Rheumatoid arthritis. Pathophysiology and implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

The T lymphocyte in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

The pathogenesis of atherosclerosis--an update

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Eosinophilic Inflammation in Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Asthma and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Endothelial-leukocyte adhesion molecules in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

The expression of leukocyte-endothelial adhesion molecules is increased in perennial allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Expression of endothelial and leukocyte adhesion molecules intercellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 in the bronchial mucosa in steady-state and allergen-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Expression of E-selectin, ICAM-1 and VCAM-1 on bronchial biopsies from allergic and non-allergic asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Interleukin-4 induces endothelial vascular cell adhesion molecule-1 (VCAM-1) by an NF-kappa b-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-alpha in cultured endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Expression of Adhesion Molecules in Early Allergic Patch Test Reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Vascular cell adhesion molecule-1: expression in normal and diseased skin and regulation in vivo by interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Expression of murine VCAM-1 in vitro and in different models of inflammation in vivo: correlation with immigration of monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Tumour necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Adhesion of human B cells to germinal centers in vitro involves VLA-4 and INCAM-110

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Targeted disruption of the murine VCAM1 gene: essential role of VCAM-1 in chorioallantoic fusion and placentation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

The pathophysiologic role of alpha 4 integrins in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Role of the VLA-4 integrin in leucocyte recruitment and bronchial hyperresponsiveness in the guinea-pig

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Monoclonal antibodies to the integrin alpha-4 subunit inhibit the murine contact hypersensitivity response.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Recruitment of lymphocytes during cutaneous delayed hypersensitivity in nonhuman primates is dependent on E-selectin and vascular cell adhesion molecule 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Treatment with anti-vascular cell adhesion molecule 1 monoclonal antibody induces long-term murine cardiac allograft acceptance

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Inhibition of insulitis and prevention of diabetes in nonobese diabetic mice by blocking L-selectin and very late antigen 4 adhesion receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Administration of monoclonal antibodies against vascular cell adhesion molecule-1/very late antigen-4 abrogates predisposing autoimmune diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

The pathogenesis of adoptive murine autoimmune diabetes requires an interaction between alpha 4-integrins and vascular cell adhesion molecule-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

The crystal structure of an N-terminal two-domain fragment of vascular cell adhesion molecule 1 (VCAM-1): a cyclic peptide based on the domain 1 C-D loop can inhibit VCAM-1-alpha 4 integrin interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Blockade of very late antigen-4 integrin binding to fibronectin with connecting segment-1 peptide reduces accelerated coronary arteriopathy in rabbit cardiac allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Pharmacological modulation of endothelial cell-associated adhesion molecule expression: implications for future treatment of dermatological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

The 3D-structure of a natural inhibitor of cell adhesion molecule expression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970075-1

7 January 2021

10.1016/S0091-6749(96)70075-1

Identifiers

DOI

1 reference

2 September 2017

1 reference